Literature DB >> 11264270

Climacteric complaints in the community.

L W Maartens1, G L Leusink, J A Knottnerus, C G Smeets, V J Pop.   

Abstract

BACKGROUND: At the onset of the climacteric, healthy middle-aged women present with a variety of complaints, especially in general practice. In these first years of entering the menopause, vaginal blood loss alters from irregular periods to complete amenorrhoea. According to these different menstrual patterns, we can distinguish a pre-, peri- and postmenopausal phase. It could be useful to know whether specific climacteric complaints are related to these different phases.
OBJECTIVE: The aim of this study was to investigate the relationship between climacteric complaints and the menstrual pattern during the menopausal transition in a population-based cross-sectional survey of healthy middle-aged women.
METHODS: All women aged 47-54 years, living in the city of Eindhoven, were invited to participate in the Eindhoven Osteoporosis Study (EPOS); 6648 (78%) agreed to participate. All women completed a questionnaire concerning climacteric complaints. Climacteric status was defined by menstrual history. Odds ratios (ORs) were obtained for the relationship between climacteric status and climacteric complaints. Multiple logistic regression analysis was carried out, with climacteric status as the dependent variable.
RESULTS: Of the 27 items in the questionnaire concerning climacteric complaints, seven were significantly different between all three climacteric phases (P: < 0.1). After multiple logistic regression analysis, comparing peri- and premenopause, only flushing (OR 5.9) was significantly different. Between post- and perimenopause, seven symptoms appeared to be different: three urogenital complaints [vaginal dryness (OR 1.6), vaginal discharge (OR 0.4) and pain during intercourse (OR 1.9)], three vasomotor symptoms [daytime sweating (OR 1.4), night-time sweating (OR 0.7) and flushing (OR 1.9)] and, finally, insomnia (OR 1.3). When comparing post- and premenopause, flushing (OR 13.4), insomnia (OR 2.1) and depressed mood (OR 0.6) were significantly different, in addition to three urogenital symptoms: vaginal dryness (OR 2.6), vaginal discharge (OR 0.3) and pain during intercourse (OR 2.1).
CONCLUSION: The major findings of the study are that flushing is strongly associated with the transition from pre- to perimenopause, while urogenital complaints, daytime sweating and insomnia are more prominent in the transition from peri- to postmenopause.

Entities:  

Mesh:

Year:  2001        PMID: 11264270     DOI: 10.1093/fampra/18.2.189

Source DB:  PubMed          Journal:  Fam Pract        ISSN: 0263-2136            Impact factor:   2.267


  6 in total

1.  DSM-IV psychiatric comorbidity according to symptoms of insomnia: a nationwide sample of Korean adults.

Authors:  Byung-Soo Kim; Hong Jin Jeon; Jin Pyo Hong; Jae Nam Bae; Jun-Young Lee; Sung Man Chang; Young-Moon Lee; Jungwoo Son; Maeng Je Cho
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-04-13       Impact factor: 4.328

Review 2.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 3.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

Review 4.  Dyspareunia in postmenopausal women: a critical review.

Authors:  A Kao; Y M Binik; A Kapuscinski; S Khalife
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

5.  Randomized, double-blind, placebo-controlled trial of Cimicifuga racemosa (black cohosh) in women with anxiety disorder due to menopause.

Authors:  Jay D Amsterdam; Yubing Yao; Jun James Mao; Irene Soeller; Kenneth Rockwell; Justine Shults
Journal:  J Clin Psychopharmacol       Date:  2009-10       Impact factor: 3.153

6.  Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination.

Authors:  Sebastian Mirkin; James H Pickar
Journal:  Int J Womens Health       Date:  2013-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.